| Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. | |
| | |
MedLine Citation:
|
PMID: 17496207 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This study was designed to quantitatively assess the mRNA expression of 36 important drug transporters in human jejunum, colon, liver, and kidney. Expression of these transporters in human organs was compared with expression in commonly used cell lines (Caco-2, HepG2, and Caki-1) originating from these organs to assess their value as in vitro transporter system models, and was also compared with data obtained from the literature on expression in rat tissues to assess species differences. Transporters that were highly expressed in the intestine included HPT1, PEPT1, BCRP, MRP2, and MDR1, whereas, in the liver, OCT1, MRP2, OATP-C, NTCP and BSEP were the main transporters. In the kidney, OAT1 was expressed at the highest levels, followed by OAT3, OAT4, MCT5, MDR1, MRP2, OCT2, and OCTN2. The best agreement between human tissue and the representative cell line was observed for human jejunum and Caco-2 cells. Expression in liver and kidney ortholog cell lines was not correlated with that in the associated tissue. Comparisons with rat transporter gene expression revealed significant species differences. Our results allowed a comprehensive quantitative comparison of drug transporter expression in human intestine, liver, and kidney. We suggest that it would be beneficial for predictive pharmacokinetic research to focus on the most highly expressed transporters. We hope that our comparison of rat and human tissue will help to explain the observed species differences in in vivo models, increase understanding of the impact of active transport processes on pharmacokinetics and distribution, and improve the quality of predictions from animal studies to humans. |
| | |
Authors:
|
Constanze Hilgendorf; Gustav Ahlin; Annick Seithel; Per Artursson; Anna-Lena Ungell; Johan Karlsson |
Related Documents
:
|
15471937 - Expression of cystic fibrosis transmembrane conductance regulator in human endometrium. 11698107 - Molecular and functional characterization of galectin 9 mrna isoforms in porcine and hu... 12184527 - Cystic fibrosis transmembrane conductance regulators (cftr) in biliary epithelium of pa... 20658517 - Slc26a9 stimulates cftr expression and function in human bronchial cell lines. 22722757 - Role of reactive oxygen species in transforming growth factor beta1-induced alpha smoot... 20691257 - Arecoline, a major alkaloid of the areca nut, causes neurotoxicity through enhancement ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2007-05-11 |
Journal Detail:
|
Title: Drug metabolism and disposition: the biological fate of chemicals Volume: 35 ISSN: 0090-9556 ISO Abbreviation: Drug Metab. Dispos. Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-07-20 Completed Date: 2007-11-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9421550 Medline TA: Drug Metab Dispos Country: United States |
Other Details:
|
Languages: eng Pagination: 1333-40 Citation Subset: IM |
Affiliation:
|
Discovery Drug Metabolism and Pharmacokinetics & Bioanalytical Chemistry, AstraZeneca Research & Development, Mölndal, Sweden. constanze.hilgendorf@astrazeneca.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
ATP-Binding Cassette Transporters
/
genetics Aged Aged, 80 and over Animals Caco-2 Cells Cell Line, Tumor Colon / metabolism Female Gene Expression Profiling* Humans Intestines / metabolism* Jejunum / metabolism Kidney / metabolism* Liver / metabolism* Male Membrane Transport Proteins / genetics* Middle Aged Principal Component Analysis Rats Reverse Transcriptase Polymerase Chain Reaction |
| Chemical | |
Reg. No./Substance:
|
0/ATP-Binding Cassette Transporters; 0/Membrane Transport Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Kinetics of valproic acid glucuronidation: evidence for in vivo autoactivation.
Next Document: Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mec...